HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 02/04/2013 -- Acme Packet Inc (NASDAQ:APKT) announced that it has entered into an agreement to be acquired by Oracle for $29.25 per share in cash representing a fully diluted equity value of $2.1 billion. The Board of Directors of Acme Packet has unanimously approved the transaction. The transaction is expected to close in the first half of 2013.
Is APKT Showing Any Sign of Buy At The Current Market Price? Find Out Here
Sonus Networks (NASDAQ:SONS) surged 9.65% to $2.50 in the pre-market session. Sonus Networks is expected to report its Q4 results on February 28, 2013. Sonus Networks, Inc. is a provider of voice and multimedia infrastructure solutions, including session border control, Voice over Internet Protocol (VoIP), access and VoIP media gateway solutions for service providers and enterprises.
Can SONS Continue To Move Lower After The Recent Gain and Investors Can Make Money? Find Out Here
Rockwell Medical (NASDAQ:RMTI) moved up 24.19% to $8.01 in the pre-market session. Rockwell Medical announced successful topline results from the PRIME clinical study of Soluble Ferric Pyrophosphate (SFP), its investigational iron-delivery drug currently in Phase 3 clinical studies for the treatment of iron deficiency in hemodialysis patients. The PRIME study demonstrated that regular administration of SFP-iron via dialysate reduced the usage of erythropoietin stimulating agents (ESAs) during hemodialysis by 37.1% while maintaining iron balance and maximizing iron deliver.
Will New Regulations Weigh over RMTI Revenue Stream? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) increased 0.87% and closed at $1.74.The Company engages in discovering, developing, and commercializing innovative therapies addressing unmet medical needs using targeted bio therapeutics. The Market Cap of the Company is 117.33 million. The Price/book ratio of the Company is 8.26.The 50-Day Moving Average and 200-Day Moving Average of the Company is 1.72 and 1.80 respectively.
How Should Investors Trade GALE After Today’s Rally? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)